06.30.25 -- Business Strategies For Trump 2.0 Policy Changes

Patient recruitment has long been a challenge for drug developers. Can the use of comprehensive, real-world data (RWD) solutions offer a faster, better way to achieve recruitment goals?

For early-stage biotech companies, the road from discovery to market is fraught with challenges, and in this environment, strategic partnerships with CROs have become a cornerstone of clinical success.

Many challenges can stall an advanced therapy’s development, and the vast majority of them are tied to inadequate preclinical planning and partner vetting. Find how to foster a better development strategy.

Reducing uncertainty about clinical trial participation through empathy, clarity, and support can build a patient confidence and encourage them to make informed, empowered decisions.

As trials continue to digitize, learn how connected sensors, COAs, and other data practices will come together to form the evidence of tomorrow—with proven, real-life examples.

As pharma companies aim to overcome development obstacles, it is important to incorporate GMP expertise alongside novel technologies that can enhance the properties of APIs and dosage forms.